The Heart Failure Policy Network

arrow-splash

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma and Vifor Pharma. Additional support for The handbook launch in September 2018 has been provided by Bayer AG. The content produced by the Network is not biased to any specific treatment or therapy, and is endorsed and owned by the Network’s members, who have full editorial control. All members provide their time for free.

The high-profile mention of #HF in #MaSanté2022 (the French national health strategy) is fully warranted by the number of people affected, and potential for evidence-driven best practice to improve lives and health outcomes across France. #ChangeHFpolicy pic.twitter.com/f7IKoigSXq